抄録
The following report is based on a clinical trial of the combination product of sulfamethoxazole (SMX) and trimethoprim (TMP) in a total of 32 patients, 18 males and 14 females, with infections in otorhinolaryngology. Clinical materials are composed of 9 cases of acute purulent otitis media, 8 cases of furuncle of the ear, 12 cases of acute lacunar tonsillitis and 3 cases of peritonsillar abscess. SMX-TMP combination product was administered orally in daily doses of 3 to 6 tab., according to the age of the patient, divied in 2 doses. The drug therapy was markedly effective in 12, moderately effective in 15, slightly effective in 2 and ineffective in 2 cases. The effective rate including marked and moderate totaled 87. 5%. No significant adverse reactions have been recorded during the study.
